TREATMENT OF A CHRONIC OBSTRUCTIVE PULMONARY DISEASE CASE WITH REGENTIME® PROCEDURE

Chronic Obstructive Pulmonary Disease (COPD) is a common disease associated with high morbidity and mortality rates. It characterized by airway parenchymal inflammation leading to narrowing, decreased lung recoil, eventual airflow limitation. Despite the advance in therapeutic approaches, no curative clinical treatment for COPD exists. We present case of 74-year-old gentleman diagnosed who underwent stem cell therapy Regentime® Procedure. This technique uses Autologous Bone Marrow -Mononuclear Stem Cells (BM-MSCs) which are partially differentiated specifically redirected desired organ. Clinical follow-up 5 years after transplantation showed decrease major symptoms, including dyspnea, cough, fatigue, oxygen requirement. However, regression was registered during past 2 patient’s requirement increased optimal saturation. The results obtained support cell-based as promising option patients suffering from COPD. KEYWORDS: Procedure, Marrow-Mesenchymal Cells, Disease.